GW604714X 是一种有效的线粒体呼吸 (mitochondrial respiration) 抑制剂。GW604714X 是一种高度特异性的线粒体丙酮酸载体 (MPC) 抑制剂，K_i <0.1 nM。GW604714X 也能抑制质膜单羧酸转运体 (MCT1) 的 L-乳酸转运，但浓度比 MPC 的大 4 个数量级。

GW604714X is a potent inhibitor of mitochondrial respiration supported by pyruvate but not other substrates. GW604714X is a highly specific mitochondrial pyruvate carrier (MPC) inhibitor with a K i <0.1 nM. GW604714X also inhibits L-lactate transport by the plasma membrane monocarboxylate transporter (MCT1), but at concentrations more than 4 orders of magnitude greater than the MPC.

Solid

GW604714X inhibits the mitochondrial pyruvate carrier (MPC) with Ki value <0.1 μM in direct measurement of pyruvate transport into rat liver and yeast mitochondria.
Inhibitor titrations of pyruvate-dependent respiration by heart mitochondria gave values for the concentration of inhibitor binding sites and their Ki (nM) of 56.0 nM and 0.057 nM for the GW604714X.
GW604714X inhibits the transport of 0.5 mM [C]-l-lactate into rat red blood cells, mediated by the monocarboxylate transporter MCT1. GW604714X at 10 μM reduces the initial rate of uptake to 30% of control values.
has not independently confirmed the accuracy of these methods. They are for reference only.

Room temperature in continental US; may vary elsewhere.

Powder -20°C 3 years；4°C 2 years

[1]. John C W Hildyard, et al. Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier. Biochim Biophys Acta. Apr-May 2005;1707(2-3):221-30.
[2]. Allen K. Bourdon, et al. Alzheimers and Parkinsons Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier - Ligand Docking to Screen Natural Compounds Related to Classic Inhibitors. DOI:10.4018/IJKDB.2017070104

In Vitro: DMF : 5.26 mg/mL (11.16 mM; Need ultrasonic and warming)配制储备液